Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Zevra Therapeutics Inc
ZVRA
Healthcare
Biotechnology
Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 2 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under...
Phase 1/2 clinical trial to treat narcolepsy. The company is also developing Celiprolol, a prodrug product candidate that is under Phase 3 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit and hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and MIPLYFFA for the treatment of niemann pick disease type C, an ultra-rare neurodegenerative lysosomal storage disorder. The company has collaboration and license agreement with Commave Therapeutics SA to de...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:ZVRA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(9875)
•••
Lisagerrard17
X
Comment by
Lisagerrard17
on Jun 06, 2022 1:50pm
RE:Support?
(2)
•••
mevani
X
Comment by
mevani
on Mar 03, 2021 12:13pm
RE:RE:RE:RE:RE:RE:RE:RE:Support?
Congrats! What a day. I have been buying the dips. I will be holding this for a bit here.
(68)
•••
Bobby90
X
Comment by
Bobby90
on Feb 11, 2021 11:49am
RE:RE:RE:RE:RE:RE:RE:Support?
After approval with 30/13 label I can see a buyout by GPC and that could cost them $3 billion. It's not just a drug with the same potential as Vyvanse ($2.6 billion buyout). KMPH has a pipeline
...more
(657)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 04, 2021 1:46pm
RE:RE:RE:RE:RE:RE:Support?
Sounds good......in the mean time..... I just take profits when they stare me in the face. Good luck to you! Cheers ps: I have no position now
(68)
•••
Bobby90
X
Comment by
Bobby90
on Feb 04, 2021 12:37pm
RE:RE:RE:RE:RE:Support?
If GPC buys them out then we can expect a share price of $30 minimum. New River Pharmaceuticals (Vyvanse) got bought out before approval for $2.6 billion.
(657)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 04, 2021 12:14pm
RE:RE:RE:RE:Support?
Still in play.......added a small position. Cheers !
(657)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 04, 2021 12:00pm
RE:RE:RE:Support?
Has to hold hold here.......here comes the pitch
(657)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 04, 2021 11:58am
RE:RE:Support?
(657)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 04, 2021 11:49am
RE:Support?
I treat these runners like a baseball game.... so far there is 2 strikes against KMPH.....so it still can rally from here.... You don't want to be holding on the 3 rd strike. Cheers !
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 04, 2021 11:45am
Support?
I figure....... $7 has to hold or game over for the short term JMHO
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 04, 2021 11:36am
Sold KMPH......
on the $7.75 failure to break. Crystalized good profit. I will be back. Cheers
(657)
•••
Iseneschal
X
Comment by
Iseneschal
on Feb 04, 2021 11:12am
RE:My thoughts for KMPH....
I would like to add that on Jan 25th KMPH sh price double topped at ~ $7.75.... That would be a crucial pivot.... JMHO Cheers !
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 04, 2021 10:21am
My thoughts for KMPH....
We're currently trading at ~ $7.50 this a.m........... We've been here before....which was last Jan25th. I'd like to see a break of this level because I feel that we could fill the gap
...more
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Feb 04, 2021 8:33am
Movin on up.......
in this a.m's Pre-market open....just sayin! My last post was a gift IMHO.......did u BTFD ?? Just added this a.m...... in other words I am re-loading Here and will add on weakness.
...more
(657)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 28, 2021 12:07pm
Just added this a.m......
in other words I am re-loading Here and will add on weakness. Cheers !
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Sranan Gold Reports 11 M Grading 7.33 g/t Gold Including 4 M at 14.59 g/t Gold
Global Currency Shifts Are Reshaping Commodities. Learn How. Secure Your Seat at VRIC 2026
Pinnacle Provides Progress Update for El Potrero Gold-Silver Project
Allied Critical Metals Announces Receipt of Environmental Permit for the Borralha Tungsten Project in Portugal
Sorrento Resources Announces Drilling Contract and Receives Permit to Drill Bottom Brook Project
Podcasts